157 related articles for article (PubMed ID: 23437147)
1. Expression and purification of functional human mu opioid receptor from E.coli.
Ma Y; Kubicek J; Labahn J
PLoS One; 2013; 8(2):e56500. PubMed ID: 23437147
[TBL] [Abstract][Full Text] [Related]
2. Expression and spectroscopic characterization of a large fragment of the mu-opioid receptor.
Kerman A; Ananthanarayanan VS
Biochim Biophys Acta; 2005 Feb; 1747(1):133-40. PubMed ID: 15680247
[TBL] [Abstract][Full Text] [Related]
3. Solubilization, purification, and mass spectrometry analysis of the human mu-opioid receptor expressed in Pichia pastoris.
Sarramegna V; Muller I; Mousseau G; Froment C; Monsarrat B; Milon A; Talmont F
Protein Expr Purif; 2005 Oct; 43(2):85-93. PubMed ID: 16095919
[TBL] [Abstract][Full Text] [Related]
4. Expression of EGFP-amino-tagged human mu opioid receptor in Drosophila Schneider 2 cells: a potential expression system for large-scale production of G-protein coupled receptors.
Perret BG; Wagner R; Lecat S; Brillet K; Rabut G; Bucher B; Pattus F
Protein Expr Purif; 2003 Sep; 31(1):123-32. PubMed ID: 12963349
[TBL] [Abstract][Full Text] [Related]
5. Differential involvement of mu(1)-opioid receptors in endomorphin- and beta-endorphin-induced G-protein activation in the mouse pons/medulla.
Mizoguchi H; Narita M; Wu H; Narita M; Suzuki T; Nagase H; Tseng LF
Neuroscience; 2000; 100(4):835-9. PubMed ID: 11036217
[TBL] [Abstract][Full Text] [Related]
6. Expression of delta, kappa and mu human opioid receptors in Escherichia coli and reconstitution of the high-affinity state for agonist with heterotrimeric G proteins.
Stanasila L; Massotte D; Kieffer BL; Pattus F
Eur J Biochem; 1999 Mar; 260(2):430-8. PubMed ID: 10095778
[TBL] [Abstract][Full Text] [Related]
7. The N-terminal end truncated mu-opioid receptor: from expression to circular dichroism analysis.
Muller I; Sarramégna V; Milon A; Talmont FJ
Appl Biochem Biotechnol; 2010 Apr; 160(7):2175-86. PubMed ID: 19636522
[TBL] [Abstract][Full Text] [Related]
8. Characterization of an engineered water-soluble variant of the full-length human mu opioid receptor.
Xi J; Xiao J; Perez-Aguilar JM; Ping J; Johnson ATC; Saven JG; Liu R
J Biomol Struct Dyn; 2020 Sep; 38(14):4364-4370. PubMed ID: 31588852
[TBL] [Abstract][Full Text] [Related]
9. Use of dual affinity tags for expression and purification of functional peripheral cannabinoid receptor.
Yeliseev A; Zoubak L; Gawrisch K
Protein Expr Purif; 2007 May; 53(1):153-63. PubMed ID: 17223358
[TBL] [Abstract][Full Text] [Related]
10. Coupling efficacy and selectivity of the human mu-opioid receptor expressed as receptor-Galpha fusion proteins in Escherichia coli.
Stanasila L; Lim WK; Neubig RR; Pattus F
J Neurochem; 2000 Sep; 75(3):1190-9. PubMed ID: 10936202
[TBL] [Abstract][Full Text] [Related]
11. Expression and purification of milligram levels of inactive G-protein coupled receptors in E. coli.
Bane SE; Velasquez JE; Robinson AS
Protein Expr Purif; 2007 Apr; 52(2):348-55. PubMed ID: 17166740
[TBL] [Abstract][Full Text] [Related]
12. Optimized Proteomic Mass Spectrometry Characterization of Recombinant Human μ-Opioid Receptor Functionally Expressed in Pichia pastoris Cell Lines.
Rosa M; Bech-Serra JJ; Canals F; Zajac JM; Talmont F; Arsequell G; Valencia G
J Proteome Res; 2015 Aug; 14(8):3162-73. PubMed ID: 26090583
[TBL] [Abstract][Full Text] [Related]
13. Characterization of a computationally designed water-soluble human μ-opioid receptor variant using available structural information.
Zhao X; Perez-Aguilar JM; Matsunaga F; Lerner M; Xi J; Selling B; Johnson AT; Saven JG; Liu R
Anesthesiology; 2014 Oct; 121(4):866-75. PubMed ID: 24835677
[TBL] [Abstract][Full Text] [Related]
14. Specific activation of the mu opioid receptor (MOR) by endomorphin 1 and endomorphin 2.
Monory K; Bourin MC; Spetea M; Tömböly C; Tóth G; Matthes HW; Kieffer BL; Hanoune J; Borsodi A
Eur J Neurosci; 2000 Feb; 12(2):577-84. PubMed ID: 10712637
[TBL] [Abstract][Full Text] [Related]
15. Biased μ-opioid receptor agonists diversely regulate lateral mobility and functional coupling of the receptor to its cognate G proteins.
Melkes B; Hejnova L; Novotny J
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1289-1300. PubMed ID: 27600870
[TBL] [Abstract][Full Text] [Related]
16. A novel non-opioid binding site for endomorphin-1.
Lengyel I; Toth F; Biyashev D; Szatmari I; Monory K; Tomboly C; Toth G; Benyhe S; Borsodi A
J Physiol Pharmacol; 2016 Aug; 67(4):605-616. PubMed ID: 27779481
[TBL] [Abstract][Full Text] [Related]
17. Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2.
Kuszak AJ; Pitchiaya S; Anand JP; Mosberg HI; Walter NG; Sunahara RK
J Biol Chem; 2009 Sep; 284(39):26732-41. PubMed ID: 19542234
[TBL] [Abstract][Full Text] [Related]
18. mu opiate receptor: cDNA cloning and expression.
Wang JB; Imai Y; Eppler CM; Gregor P; Spivak CE; Uhl GR
Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10230-4. PubMed ID: 8234282
[TBL] [Abstract][Full Text] [Related]
19. Novel highly potent mu-opioid receptor antagonist based on endomorphin-2 structure.
Fichna J; do-Rego JC; Janecki T; Staniszewska R; Poels J; Broeck JV; Costentin J; Schiller PW; Janecka A
Bioorg Med Chem Lett; 2008 Feb; 18(4):1350-3. PubMed ID: 18207400
[TBL] [Abstract][Full Text] [Related]
20. Molecular identification and functional expression of mu 3, a novel alternatively spliced variant of the human mu opiate receptor gene.
Cadet P; Mantione KJ; Stefano GB
J Immunol; 2003 May; 170(10):5118-23. PubMed ID: 12734358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
